Lymphokine-activated killer lymphocytes: LAK and interleukin-2 in the treatment of malignancies of the central nervous system.

J. B. Blacklock, E. A. Grimm

Research output: Contribution to journalArticlepeer-review

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)93-99
Number of pages7
JournalImmunology series
Volume48
StatePublished - 1989

Cite this